# Bioimpedance-guided Fluid Management in Chronic Peritoneal Dialysis Patients.

Study · id `cardio:ct-nct03004963` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03004963](<https://clinicaltrials.gov/study/NCT03004963>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03004963

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 213 participants.

## Technical summary

Registry record NCT03004963. Randomized; no masking; primary purpose treatment. Start 2016-11 (actual); primary completion 2020-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 213 participants (enrolled count; ClinicalTrials.gov record NCT03004963, source copy `cardio:ctgov-nct03004963-2024-11-22`, retrieved 2026-10-26)
- Started: 2016-11 (actual) (ClinicalTrials.gov record NCT03004963, source copy `cardio:ctgov-nct03004963-2024-11-22`, retrieved 2026-10-26)
- Primary completion: 2020-11 (actual) (ClinicalTrials.gov record NCT03004963, source copy `cardio:ctgov-nct03004963-2024-11-22`, retrieved 2026-10-26)
- Completion: 2020-11 (actual) (ClinicalTrials.gov record NCT03004963, source copy `cardio:ctgov-nct03004963-2024-11-22`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03004963, source copy `cardio:ctgov-nct03004963-2024-11-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03004963-2024-11-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Bioimpedance-guided Fluid Management in Chronic Peritoneal Dialysis Patients.
- Condition: End Stage Renal Disease
- Intervention (Device): Body composition monitor
- Intervention (Device): clinical indexes
- Lead sponsor: RenJi Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: RenJi Hospital (`cardio:org-renji-hospital`)

## Provenance

Content hash: 7f8da7c32ca65ca69a61bb6df0161556f62ddf56d9e3b2a25350c03ff9bd7e6f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
